Prof. Dr. Rainer Fischer has been Department Head of the Institute for Molecular Biotechnology (RWTH Aachen University, Germany, 70 employees) and Senior Executive Director of the Fraunhofer Institute for Molecular Biology and Applied Ecology (680 employees including the Fraunhofer US CMB and Fraunhofer Chile Research CSB with german subsidiaries in Aachen, Schmallenberg, Münster, Giessen, Frankfurt and Hamburg). As of April 1st 2017 Prof. Fischer assumed a new position as CSIO at the IBRI (Indiana Biosciences Research Institute) in Indianapolis, IN, USA.
His expertise covers many areas of molecular biotechnology including genomics, proteomics, cellomics, protein engineering, molecular medicine, immunology, virology, plant biotechnology, as well as the production and purification of recombinant proteins, secondary metabolites and plant derived polymers as well as regulatory approval.
Over the past 15 years, Prof. Fischer has established the Fraunhofer IME in Germany and its foreign subsidiary the Fraunhofer CMB in Newark, DE, USA, and most recently the Fraunhofer Center for Systems Biotechnology in Chile, as well as the Institute for Molecular Biotechnology at the RWTH Aachen University. He is the cofounder of five biotech start-ups and the Aachen-Maastricht Institute of Biobased Materials (AMIBM). Together with his team he has raised over 800 million Euro in funding for Fraunhofer IME in Germany, more than 180 million USD in the US and Chile and over 30 million Euro for RWTH Aachen University.
110 PhD, over 200 master & diploma students and 100 bachelor students have graduated from the institutes led by Prof. Fischer. Furthermore, Prof. Fischer has given over 650 scientific presentations, written over 330 peer-reviewed scientific publications and published 52 book chapters. His papers have been cited over 15.000 times and his current H-factor is 64. Additionally, he holds 64 pending patent applications and 40 granted patents.